Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Karim Bennaceur.

Newcastle AuthorsTitleYearFull text
Dr Bilal Bawamia
Dr Luke Spray
Vincent Wangsaputra
Dr Karim Bennaceur
Dr Sharareh Vahabi
et al.
Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction Randomized Pilot Trial2023
Dr Kateryna Sopova
Dr Simon Tual-Chalot
Dr Nikolaos Vlachogiannis
Dr Georgios Georgiopoulos
Dr Luke Spray
et al.
Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction2023
Dr Rachael Redgrave
Dr Esha Singh
Dr Simon Tual-Chalot
Dr Catherine Park
Dr Darroch Hall
et al.
Exogenous Transforming Growth Factor-β1 and Its Helminth-Derived Mimic Attenuate the Heart's Inflammatory Response to Ischemic Injury and Reduce Mature Scar Size2023
Professor Ioakim Spyridopoulos
Dr Bilal Bawamia
Dr Luke Spray
Vincent Wangsaputra
Professor Konstantinos Stellos
et al.
Activation of mitochondrial telomerase reverses relative lymphopenia post myocardial infarction: results from the randomised, double-blinded TACTIC phase IIa pilot trial2022
Dr Catherine Park
Dr Suzanne Cormack
Dr Ashfaq Mohammed
Dr Stephen Boag
Dr Karim Bennaceur
et al.
The Fractalkine Receptor CX3CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling2021
Dr Catherine Park
Dr Suzanne Cormack
Dr Stephen Boag
Dr Karim Bennaceur
Dr Gavin Richardson
et al.
Role of CMV-serostatus and CX3CR1 on lymphocyte kinetics and left ventricular remodelling in patients with acute myocardial infarction2020
Rebecca Maier
Dr Bilal Bawamia
Dr Karim Bennaceur
Sarah Dunn
Dr Leanne Marsay
et al.
Telomerase activation to reverse immunosenescence in elderly patients with acute coronary syndrome: Protocol for a randomized pilot trial2020
Dr Gavin Richardson
Dr Karim Bennaceur
Emily Dookun
Lilia Draganova
Dr Gabriele Saretzki
et al.
Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells2018
Dr Catherine Drummond
Arman Esfandiari
Dr Xiaohong Lu
Dr Claire Hutton
Dr Jennifer Jackson
et al.
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation2016
Rachael Horbury
Dr Karim Bennaceur
Catriona Barker
Professor David Kavanagh
Professor Tim Goodship
et al.
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)2015
Dr Evgeniya Shmeleva
Dr Stephen Boag
Santosh Murali
Dr Karim Bennaceur
Dr Rajiv Das
et al.
Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion2015
Dr Stephen Boag
Dr Rajiv Das
Dr Evgeniya Shmeleva
Dr Alan Bagnall
Dr Mohaned Egred
et al.
T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients2015
Dr Karim Bennaceur
Mark Atwill
Nayef Al Zhrany
Jedrzej Hoffmann
Professor Bernard Keavney
et al.
Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism2014
Dr Evgeniya Shmeleva
Dr Stephen Boag
Santosh Murali
Dr Karim Bennaceur
Dr Stephen Todryk
et al.
Effect of CMV-seropositivity on acute outcome of acute myocardial infarction2014
Professor David Kavanagh
Dr Isabel Pappworth
Christine Hayes
Dr Iain Moore
Dr Eva-Maria Hunze
et al.
Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome: Disease-Associated or an Epiphenomenon?2012
Dr Karim Bennaceur
Dr Eva-Maria Hunze
James Staniforth
Dr Lisa Turnbull
Dr Valerie Wilson
et al.
MCP (CD46) autoantibodies are associated with atypical hemolytic uremic syndrome2012
Dr Ian Hardcastle
Alex Liu
Dr Eric Valeur
Anna Watson
Shafiq Ahmed
et al.
Isoindolinone Inhibitors of the Murine Double Minute 2 (MDM2)-p53 Protein-Protein Interaction: Structure-Activity Studies Leading to Improved Potency2011
Dr Karim Bennaceur
Dr Catherine Drummond
Professor Jane Endicott
Emeritus Professor Bernard Golding
Professor Roger Griffin
et al.
MDM2-p53 protein-protein interaction inhibitors: A-ring substituted isoindolinones2011
Dr Karim Bennaceur
Different mechanisms are involved in apoptosis induced by melanoma gangliosides on human monocyte-derived dendritic cells2009
Dr Karim Bennaceur
Immunosuppressive networks in the tumour environment and their effect in dendritic cells2009
Dr Karim Bennaceur
Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis2006
Dr Karim Bennaceur
Studies of compounds that enhance sphingolipid metabolism in human keratinocytes2006